ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM

Clinical trials for ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM explained in plain language.

Never miss a new study

Get alerted when new ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM trials appear

Sign up with your email to follow new studies for ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Tracking baby health: study follows pregnant women on rare disease drug

Knowledge-focused Recruiting now

This study aims to gather information on the safety of the drug Ultomiris (ravulizumab) during pregnancy and breastfeeding. It will follow about 75 women who have rare conditions like PNH or aHUS and who took Ultomiris while pregnant. Researchers will track the health of both the…

Matched conditions: ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM

Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused

Last updated Feb 23, 2026 14:57 UTC

ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM

Get alerted when new ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM trials appear

Tracking baby health: study follows pregnant women on rare disease drug